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Lung Cancer – 2015 United States Estimates 
 
▪ 221,200 cases (115,610 Male and 105,590 Female) 
▪ More deaths than next four most common cancers combined 
• 158,040 deaths total 
• 86,380 Male  
• 71,660 Female 
▪ 13% of all cancer diagnoses 
▪ From 2007 to 2011 lung cancer incidence rates decreased by 3.0% per year in men and 2.2% in 
women 
▪ Overall Survival Rates  
• One year: 44%  
• Five Year: 17% 
▪ Early stage Lung cancer (Stage I and II): 
• Percentage of total diagnoses:  14% 
• Percentage of five-year survival: 54% 
 
▪ Source: Cancer Facts & Figures 2015 
Background 
▪ The surgical management of benign and malignant lung 
lesions is an evolving field 
▪ Techniques for anatomic pulmonary resection: 
• Rib-Sparing Thoracotomy (Current standard of care) 
• Video-Assisted Thoracoscopic Surgery 
• Robotic-Assisted Lung Resection 
Background 
▪ Video Assisted Thoracoscopic Surgery (VATS) paralleled 
laparoscopy offering a minimally invasive alternative to 
thoracotomy 
• Similar mortality rates and long term survival rates with: 
– Less morbidity 
– Less postoperative pain 
– Faster return to work compared to thoracotomy 
• Limitations of VATS 
– Lack of depth perception 
– Rigid instruments 
– High learning curve 
 
Background 
▪ Robotic surgery may offer a minimally invasive technique 
that is safe, efficacious and easier to learn than VATS 
• Less post-operative pain 
• Shorter hospital length of stay  
• Better early post-operative quality of life scores 
▪ This study assesses the efficacy and perioperative 
outcomes of robotic-assisted pulmonary sublobar 
resection. 
Methods 
▪ Retrospective chart review at LVHN from October 2011 to June 2014 
▪ All anatomic lung resections evaluated 
• Excluded 
– Open or VATS cases 
– Lobectomies, sleeve lobectomies, pneumonectomies, wedge resections 
▪ 626 lung resections performed 
• 186 robotic pulmonary resections performed 
• 36 robotic segmentectomies 
▪ Perioperative outcomes evaluated: 
• Length of stay  30-Day Mortality 
• Operating room time Conversion rate   
• Estimated blood loss Hospital based complications 
• Number of lymph nodes Tumor size  
• Surgical margins  Recurrence 
▪ Robotic segmentectomies that required conversions were excluded 
from further analysis. 
 
Methods 
▪ All cases were performed by a single surgeon 
using the Da Vinci Robotic Surgical platform 
Results 
Mean Range 
Age 65.4 41 – 83 
BMI 27.9 17.9 – 42.3 
Operative time 121 min 49 – 315 min 
Estimated blood loss 51.9 mL 20 – 150 mL 
Tumor size 1.57 cm 0.7 – 3 cm 
Lymph Node Stations 3.32 0 – 7 
Lymph Nodes 4.85 0 – 10 
Results 
Outcome Number Percentage 
Positive margins 0 0% 
Recurrence 1 2.94% 
Readmission rate 4 11.76% 
30-day mortality 0 0% 
Conversion Rate* 2 5.56% 
Median length of stay 2 days Range 1-17 
*Excluded from overall complication rates 
Results 
Hospital-based Complication Number Percentage 
Air leak (>5 days) 4 11.76% 
Pleural effusion 2 5.88% 
Recurrent pneumothorax 1 2.94% 
Atrial fibrillation 1 2.94% 
Acute kidney injury 1 2.94% 
Acute blood loss anemia 1 2.94% 
Discharged with chest tube 7 20.59% 
Discussion 
▪ Approximately 20-30% of anatomic lung 
resections are performed using VATS 
•Technical difficulty of VATS may be barrier to 
minimally invasive chest surgery 
Discussion 
▪ Increased identification of solitary pulmonary 
nodules 
▪ Controversy regarding sublobar resection of 
early stage NSCLC 
• Adequate lymph node sampling 
• Preserves lung volume and function 
• Controversy: equivalent oncologic outcomes as a 
traditional lobectomy 
Discussion 
▪ Potential Benefits of Robotic Surgery 
• High definition 3-D camera 
• Wristed instruments with 7 degrees of freedom 
• Dampening of tremor 
• Ability to control camera and up to 3 instruments 
simultaneously 
• Shorter learning curve compared to VATS 
Conclusions 
▪ This study demonstrates the feasibility, safety, and 
efficacy of robotic-assisted pulmonary sublobar resection 
for the treatment of isolated lung tumors.   
 
▪ Further areas of research should focus on comparisons 
to VATS procedures, cost-benefit analysis and oncologic 
efficacy. 
• Longer follow-up period is needed to assess long term 
oncologic efficacy 
• Cost analysis should be performed to evaluate if the higher 
price of the robotic systems outweigh the possibly decreased 
OR time and hospital stay. 
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